Veeva Basics Revolutionizes Biotech Operations
Veeva Systems (NYSE: VEEV) has made significant strides in the biotechnology sector by offering solutions that are tailored to the unique demands of biotechs. With more than 75 biotech companies currently utilizing Veeva Basics, these applications are proving invaluable in enhancing efficiency and reducing operational costs in the clinical, regulatory, and quality areas.
This innovative software suite is designed with fast-growing companies in mind, offering pre-configured and pre-validated applications that are not only easy to deploy but also adaptable to the evolving needs of companies as they scale. The momentum around Veeva Basics showcases a broader trend where biotechs are moving away from isolated entry-level tools and adopting comprehensive, best-in-class solutions.
New Applications for Enhanced Management
Veeva Basics provides a range of applications specifically created for clinical trial management and regulatory submissions. Two new key applications have recently been introduced:
Veeva CTMS Basics
This tool supports clinical trial management, helping teams manage milestones, monitor progress, resolve issues, and maintain site communications effectively.
Veeva Submissions Publishing Basics
This application streamlines the process of building, publishing, and transmitting regulatory submissions, enabling biotechs to manage everything in one cohesive system.
Steve Harper, the general manager of Veeva Basics, has highlighted that an increasing number of biotechs in various regions are adopting these solutions. He mentioned, "The efficiencies driven by our pre-configured and pre-validated solutions are lessening the burden of time and effort involved in compliance. By ensuring that our cloud applications remain current, biotechs can access the latest features and maintain adherence to regulatory requirements."
Global Availability and Customization
Both Veeva CTMS Basics and Submissions Publishing Basics are readily available in markets like North America and Europe. These offerings are built atop the established Vault Platform, allowing biotechnical firms to enhance their technology framework as they grow. This flexibility is critical as biotechs navigate their expansion journeys.
One user, Ian Hodgson, Ph.D., the chief operating officer at Corbus Pharmaceuticals, remarked, "Veeva Basics is a game changer that grants access to cutting-edge applications usually reserved for larger organizations. With our growth trajectory, Veeva's adaptable platform is essential to staying updated with evolving regulatory standards."
Moreover, Joe Thornton, associate director of clinical operations at Scancell, noted, "As we scale our trials, Veeva eTMF Basics provides enhanced control over our data, ensuring we stay prepared for inspections. Utilizing industry-leading best practices is our foundation, facilitating innovation in the development of new immunotherapies."
Rebecca Deng, Ph.D., associate director of regulatory affairs at Terns Pharmaceuticals, shared her appreciation for the global support and training available with Veeva Basics. She stated, "Having a simplified go-live path and validation process has resulted in substantial time and resource savings."
About Veeva Systems
Recognized as a global leader in cloud software within the life sciences sector, Veeva Systems is dedicated to innovation and steering product excellence. Serving more than 1,000 customers, including both leading biopharmaceutical giants and emerging biotech companies, Veeva continues to remain focused on balancing the needs of all stakeholders, including customers and employees.
Frequently Asked Questions
What is Veeva Basics?
Veeva Basics is a suite of cloud-based applications designed specifically for biotech companies to enhance their operational efficiency in clinical, regulatory, and quality management.
How many biotechs are currently using Veeva Basics?
More than 75 biotech companies have adopted Veeva Basics for their clinical and regulatory needs.
What new applications have been added to Veeva Basics?
The latest additions include Veeva CTMS Basics for clinical trial management and Veeva Submissions Publishing Basics for regulatory submissions.
Where are Veeva Basics applications available?
Veeva Basics is currently available in North America and Europe.
How does Veeva Basics benefit biotech companies?
It provides pre-configured solutions that accelerate deployment and offer scalability, ensuring companies can stay compliant and efficient as they grow.
